FDA
This week’s big story: Stop banning exports of medical products, report says
March 10 by Leila HawkinsPharma Logistics IQ dives into a new report calling for international cooperation and an end to banning medical exports.
FDA moves to prevent shortages and Dr. Reddy’s blockchain solution
January 13 by Leila HawkinsThe latest Pharma Logistics IQ news update reveals the FDA’s move to make guidance on supply shortages permanent, and Dr. Reddy’s project to develop a blockchain logistics solution
Anesthesia drug supply shortages and Brexit concerns
January 06 by Leila HawkinsThe latest Pharma Logistics IQ news update reveals shortages of anesthesia drugs, Brexit concerns and disruptions to Novo Nordisk's obesity drug
Saleable Returns Verification: What you need to know about enforcement discretion
August 01 by Pharma IQDan Walles of TraceLink discusses whether an enforcement delay on the next stage of the DSCSA is warranted
Why we need to improve transparency in the pharmaceutical supply chain
June 28 by Pharma Logistics EditorHow changes in the industry may end up benefiting drug prices and transparency
Top Trends in pharma logistics for 2019
January 24 by Pharma Logistics EditorWe share insights from our audience on the top trends coming this year in the temperature controlled supply chain
FDA cracks down on websites selling illegal and potentially dangerous drugs
November 29 by Pharma Logistics Editor465 websites are set to be targeted for selling unapproved versions of opioid, oncology and antiviral prescription drugs
One month away from DSCSA Deadline: Is the pharmaceutical industry ready?
November 01 by Pharma Logistics EditorExperts weigh in on whether the pharma industry is ready to meet the 27th November DSCSA enforcement deadline
A serialized guide to serialization #2
October 01 by Pharma Logistics EditorIn our second article on serialization, Pharma Logistics IQ looks at aggregation and examines why it perhaps should be a part of your strategy.
Anti-PD-1 clinical trials: What you need to know
August 08 by George Clinical RepresentativeA look into anti-PD-1 clinical trials, which aim to stop a protein found in cells within the immune system primarily responsible for halting T-cell inflammatory activity.
Cold Chain News: Q1 Highlights
April 20 by Pharma LogisticsThe first quarter of 2016 hosted plenty of activity from the pharma and cold chain industries. This was seen in the form of patent challenges, landmark agreements, extreme market reactions as we...
Your Quarterly Dose of Cold Chain & Pharma News - Q4's Highlights
December 22 by Pharma LogisticsThe final quarter of 2015 saw a number of high level collaboration announcements in the pharma space, including the highly anticipated potential Pfizer and Allergan merger. Key advancements were spott...